Industry4h ago
Isomorphic Labs Raises $2.1 Billion For Drug Discovery
Isomorphic Labs raised $2.1 billion to accelerate its AI-driven drug discovery engine. The Google DeepMind spinoff partnered with Novartis and Eli Lilly to identify hidden drug targets. This capital injection supports a technical framework designed to bypass traditional discovery bottlenecks. Practitioners should watch if these partnerships yield viable clinical candidates faster than legacy methods.